A detailed history of Atlantic Edge Private Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atlantic Edge Private Wealth Management, LLC holds 325 shares of NVO stock, worth $36,806. This represents 0.02% of its overall portfolio holdings.

Number of Shares
325
Previous 200 62.5%
Holding current value
$36,806
Previous $25.7 Million 80.65%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$122.71 - $146.91 $15,338 - $18,363
125 Added 62.5%
325 $46.4 Million
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $17,556 - $21,090
200 New
200 $20.7 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $256B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Atlantic Edge Private Wealth Management, LLC Portfolio

Follow Atlantic Edge Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atlantic Edge Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atlantic Edge Private Wealth Management, LLC with notifications on news.